Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Pollyea

Concepts (462)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
105
2024
534
25.280
Why?
Bridged Bicyclo Compounds, Heterocyclic
32
2024
171
8.330
Why?
Antineoplastic Combined Chemotherapy Protocols
43
2024
1353
7.420
Why?
Myelodysplastic Syndromes
28
2023
119
6.750
Why?
Sulfonamides
27
2024
445
6.550
Why?
Azacitidine
22
2024
129
6.000
Why?
Mutation
33
2024
3350
3.200
Why?
Isocitrate Dehydrogenase
13
2022
38
3.160
Why?
Hematologic Neoplasms
10
2023
136
3.050
Why?
Antineoplastic Agents
23
2023
1879
3.010
Why?
Neoplasm, Residual
7
2024
104
2.440
Why?
Neoplastic Stem Cells
12
2023
332
2.250
Why?
Hematopoietic Stem Cell Transplantation
15
2023
520
2.170
Why?
Triazines
7
2021
36
2.070
Why?
Aminopyridines
7
2021
81
2.010
Why?
Graft vs Host Disease
8
2022
212
1.760
Why?
Remission Induction
15
2021
233
1.640
Why?
RNA Splicing Factors
3
2020
49
1.520
Why?
Humans
147
2024
115044
1.410
Why?
Phosphoproteins
3
2020
298
1.340
Why?
Cytarabine
8
2022
51
1.300
Why?
Neoplasm Recurrence, Local
5
2020
856
1.280
Why?
Aged
54
2024
19119
1.250
Why?
Leukemia
4
2023
209
1.190
Why?
Prognosis
24
2024
3334
1.150
Why?
Aged, 80 and over
29
2024
6357
1.140
Why?
Salvage Therapy
5
2023
126
1.080
Why?
Clonal Evolution
2
2017
27
1.050
Why?
Nuclear Proteins
5
2018
593
0.960
Why?
Treatment Outcome
29
2024
9122
0.950
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2022
57
0.950
Why?
fms-Like Tyrosine Kinase 3
4
2017
43
0.940
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2023
256
0.930
Why?
Carrier Proteins
3
2017
696
0.880
Why?
Drug Resistance, Neoplasm
6
2020
636
0.870
Why?
Molecular Targeted Therapy
6
2020
347
0.860
Why?
Leukemia, Neutrophilic, Chronic
3
2019
5
0.850
Why?
Thrombocytopenia
2
2023
178
0.820
Why?
Spliceosomes
2
2020
38
0.820
Why?
Dancing
1
2022
14
0.820
Why?
Cord Blood Stem Cell Transplantation
3
2020
91
0.810
Why?
Proto-Oncogene Proteins c-bcl-2
4
2018
213
0.790
Why?
Anemia
2
2020
144
0.790
Why?
Enzyme Inhibitors
5
2020
752
0.790
Why?
Middle Aged
41
2024
26827
0.760
Why?
Febrile Neutropenia
1
2020
3
0.740
Why?
Splicing Factor U2AF
2
2023
16
0.710
Why?
Serine-Arginine Splicing Factors
2
2019
19
0.690
Why?
Receptors, Colony-Stimulating Factor
2
2017
5
0.680
Why?
DNA Methylation
3
2019
496
0.670
Why?
Transplantation Conditioning
8
2022
150
0.660
Why?
Phenylurea Compounds
7
2020
82
0.630
Why?
Male
50
2024
55731
0.610
Why?
Female
55
2024
59614
0.610
Why?
Staurosporine
1
2017
21
0.600
Why?
Stem Cells
3
2020
546
0.600
Why?
Benzimidazoles
6
2020
137
0.580
Why?
Gene Frequency
2
2017
483
0.540
Why?
Recurrence
9
2023
941
0.540
Why?
Glycine
4
2021
153
0.530
Why?
High-Throughput Nucleotide Sequencing
2
2018
441
0.530
Why?
Adult
29
2024
30656
0.530
Why?
Monocytes
2
2018
503
0.530
Why?
Skin Neoplasms
1
2023
758
0.520
Why?
Signal Transduction
9
2022
4525
0.520
Why?
Neoplasms, Plasma Cell
1
2015
7
0.520
Why?
Leukocytosis
1
2015
35
0.520
Why?
Retrospective Studies
15
2024
12547
0.510
Why?
Gene Expression
1
2020
1423
0.510
Why?
Epigenesis, Genetic
1
2019
524
0.510
Why?
Computational Biology
1
2019
532
0.500
Why?
Precision Medicine
1
2018
340
0.500
Why?
Medical Oncology
4
2023
227
0.480
Why?
Pyridines
5
2023
425
0.480
Why?
Patient Safety
1
2018
277
0.480
Why?
Maximum Tolerated Dose
5
2019
183
0.470
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
2014
94
0.450
Why?
Hematopoiesis
4
2020
172
0.450
Why?
Pyrazoles
1
2017
362
0.450
Why?
Neoplasm Proteins
4
2022
385
0.450
Why?
Apoptosis
4
2018
2366
0.440
Why?
Immunity, Innate
1
2019
723
0.440
Why?
Germ-Line Mutation
3
2022
131
0.430
Why?
Dose-Response Relationship, Drug
7
2021
1857
0.430
Why?
Oxidative Phosphorylation
5
2022
156
0.420
Why?
Leukemia, Myeloid
1
2012
40
0.420
Why?
Glutarates
1
2012
6
0.420
Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
26
0.400
Why?
Antibodies, Monoclonal, Humanized
7
2023
665
0.400
Why?
Protein Kinase Inhibitors
9
2018
786
0.400
Why?
Neoplasms
4
2018
2106
0.390
Why?
Follow-Up Studies
8
2020
4420
0.390
Why?
RNA Splicing
4
2023
246
0.390
Why?
Neutrophils
2
2023
1164
0.390
Why?
Drug Delivery Systems
1
2014
296
0.390
Why?
United States Food and Drug Administration
2
2022
172
0.370
Why?
Survival Rate
10
2020
1646
0.360
Why?
Aldehyde Dehydrogenase
3
2017
131
0.350
Why?
Rhipicephalus sanguineus
1
2009
1
0.350
Why?
Triatoma
1
2009
5
0.350
Why?
Wasps
1
2009
8
0.350
Why?
Insect Bites and Stings
1
2009
13
0.340
Why?
Syncope
1
2009
37
0.340
Why?
Cytokines
4
2020
1843
0.330
Why?
Immunotherapy, Adoptive
2
2022
184
0.330
Why?
Electron Transport Complex II
2
2019
23
0.320
Why?
Kaplan-Meier Estimate
5
2020
814
0.320
Why?
Mutant Proteins
2
2019
95
0.320
Why?
Administration, Oral
4
2018
730
0.320
Why?
Influenza A Virus, H1N1 Subtype
1
2010
139
0.310
Why?
Acute Disease
3
2023
915
0.310
Why?
Cell Self Renewal
2
2019
49
0.310
Why?
Proto-Oncogene Proteins
2
2018
609
0.310
Why?
Bone Marrow
4
2017
247
0.310
Why?
Young Adult
13
2021
10498
0.300
Why?
Transplantation, Homologous
6
2022
390
0.300
Why?
Survival Analysis
6
2020
1211
0.300
Why?
Gene Expression Regulation, Leukemic
3
2016
49
0.290
Why?
Drug Administration Schedule
4
2020
719
0.290
Why?
Anaphylaxis
1
2009
148
0.280
Why?
Disease-Free Survival
5
2022
617
0.280
Why?
Thrombocythemia, Essential
2
2016
6
0.270
Why?
Primary Myelofibrosis
2
2016
9
0.270
Why?
Polycythemia Vera
2
2016
12
0.270
Why?
Clinical Trials as Topic
4
2020
937
0.270
Why?
Hematopoietic Stem Cells
3
2022
344
0.260
Why?
Cytogenetic Analysis
2
2022
29
0.250
Why?
Biomarkers, Tumor
4
2019
1045
0.250
Why?
Animals
24
2023
31867
0.250
Why?
Influenza Vaccines
1
2010
496
0.250
Why?
DEAD-box RNA Helicases
2
2015
56
0.250
Why?
Influenza, Human
1
2010
546
0.230
Why?
Stem Cell Transplantation
3
2023
149
0.230
Why?
Induction Chemotherapy
2
2021
56
0.230
Why?
Allografts
2
2021
124
0.230
Why?
Antibodies, Monoclonal
4
2017
1268
0.230
Why?
DNA-Binding Proteins
1
2010
1318
0.220
Why?
Mice
16
2023
14927
0.220
Why?
Finland
1
2023
69
0.220
Why?
DNA Mutational Analysis
4
2019
372
0.220
Why?
RNA, Messenger
1
2010
2563
0.220
Why?
Drug Therapy, Combination
4
2022
955
0.220
Why?
Disease Management
4
2021
563
0.210
Why?
Uncertainty
1
2023
95
0.210
Why?
Antibodies, Neoplasm
3
2007
30
0.210
Why?
Clinical Trials, Phase I as Topic
1
2022
45
0.210
Why?
Clinical Trials, Phase III as Topic
1
2022
82
0.210
Why?
Disease Progression
3
2023
2389
0.210
Why?
Proto-Oncogene Proteins c-myc
2
2022
115
0.210
Why?
Interleukin-3 Receptor alpha Subunit
2
2019
17
0.210
Why?
Lymphoma, Non-Hodgkin
1
2023
71
0.200
Why?
Hematology
1
2022
13
0.200
Why?
Thalidomide
2
2012
28
0.200
Why?
Amino Acid Transport System ASC
1
2022
10
0.200
Why?
Myeloproliferative Disorders
1
2022
26
0.200
Why?
Succinate Dehydrogenase
2
2019
42
0.200
Why?
Minor Histocompatibility Antigens
1
2022
41
0.200
Why?
Receptors, Mitogen
1
2021
8
0.190
Why?
Polymerase Chain Reaction
1
2024
999
0.190
Why?
Lectins, C-Type
1
2021
61
0.190
Why?
Erythroblasts
1
2020
12
0.180
Why?
Blood Cell Count
1
2020
51
0.180
Why?
Lipase
1
2020
57
0.180
Why?
STAT3 Transcription Factor
1
2022
174
0.180
Why?
Cell Transformation, Neoplastic
3
2018
311
0.180
Why?
Inflammation Mediators
2
2020
476
0.180
Why?
Histocompatibility Testing
2
2019
116
0.170
Why?
Dendritic Cells
1
2023
436
0.170
Why?
Tumor Lysis Syndrome
1
2019
7
0.170
Why?
Immunoconjugates
1
2021
87
0.170
Why?
United States
5
2023
12226
0.170
Why?
Chemical and Drug Induced Liver Injury
1
2021
125
0.170
Why?
Age Factors
5
2022
2894
0.170
Why?
Genomics
3
2019
641
0.170
Why?
Fatty Acids
2
2020
385
0.170
Why?
Genetic Testing
2
2019
380
0.170
Why?
Leukopoiesis
1
2019
10
0.170
Why?
Myeloid Progenitor Cells
1
2019
15
0.160
Why?
Mycoses
1
2019
66
0.160
Why?
NADPH Oxidase 2
1
2019
42
0.160
Why?
NF-kappa B p50 Subunit
1
2019
25
0.160
Why?
RAW 264.7 Cells
1
2019
41
0.160
Why?
K562 Cells
1
2019
73
0.160
Why?
Tumor Suppressor Protein p53
1
2022
447
0.160
Why?
Tricarboxylic Acids
1
2018
10
0.160
Why?
Ketoglutaric Acids
1
2018
15
0.160
Why?
Mitochondrial Proteins
2
2018
220
0.160
Why?
Antibodies
1
2021
372
0.160
Why?
Hematologic Diseases
1
2019
55
0.160
Why?
Amino Acids
2
2020
451
0.160
Why?
Antibiotic Prophylaxis
1
2019
96
0.160
Why?
Antimetabolites, Antineoplastic
1
2018
81
0.160
Why?
Thiotepa
1
2018
19
0.150
Why?
Lymphoma
2
2017
178
0.150
Why?
Randomized Controlled Trials as Topic
2
2020
1214
0.150
Why?
Trees
1
2018
62
0.150
Why?
Cysteine
1
2019
171
0.150
Why?
Fusion Proteins, bcr-abl
2
2014
61
0.140
Why?
Mediastinal Neoplasms
1
2017
32
0.140
Why?
Confidence Intervals
1
2018
306
0.140
Why?
HLA-DR Antigens
1
2018
220
0.140
Why?
Hematinics
1
2017
18
0.140
Why?
Cohort Studies
5
2022
4904
0.140
Why?
AMP-Activated Protein Kinases
1
2018
175
0.140
Why?
Energy Metabolism
2
2019
729
0.140
Why?
Infusions, Intravenous
1
2018
372
0.140
Why?
Periodicals as Topic
1
2019
181
0.140
Why?
Hedgehog Proteins
1
2018
172
0.140
Why?
Pyrimidines
2
2017
375
0.140
Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
63
0.140
Why?
Genome, Human
1
2018
351
0.140
Why?
Biomarkers
3
2022
3419
0.140
Why?
Glucosephosphate Dehydrogenase
1
2016
37
0.140
Why?
Unrelated Donors
1
2016
37
0.140
Why?
Geriatric Assessment
1
2018
176
0.130
Why?
Leukocyte Count
1
2017
292
0.130
Why?
Nitriles
1
2017
152
0.130
Why?
Electronic Health Records
1
2023
799
0.130
Why?
NF-E2-Related Factor 2
1
2016
71
0.130
Why?
Oncogene Proteins
1
2016
53
0.130
Why?
Genetic Predisposition to Disease
2
2022
2108
0.130
Why?
Lipopolysaccharides
1
2019
817
0.130
Why?
Programmed Cell Death 1 Receptor
1
2017
193
0.130
Why?
Mice, Inbred NOD
4
2019
559
0.130
Why?
Methyltransferases
1
2016
61
0.130
Why?
Mitochondria
2
2018
750
0.130
Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2015
13
0.130
Why?
Myeloid-Lymphoid Leukemia Protein
1
2016
62
0.130
Why?
Hemoglobins
2
2018
315
0.130
Why?
Chromosome Aberrations
1
2015
135
0.120
Why?
T-Lymphocytes
1
2022
1747
0.120
Why?
Oligomycins
1
2014
8
0.120
Why?
Mitochondrial Proton-Translocating ATPases
1
2014
17
0.120
Why?
Homeostasis
1
2018
578
0.120
Why?
Histone-Lysine N-Methyltransferase
1
2016
95
0.120
Why?
Cell Survival
4
2022
1022
0.120
Why?
In Situ Hybridization, Fluorescence
1
2015
310
0.120
Why?
Necrosis
1
2015
210
0.120
Why?
Adolescent
6
2019
17864
0.120
Why?
Calcineurin Inhibitors
1
2014
58
0.120
Why?
Predictive Value of Tests
1
2019
1812
0.120
Why?
Cells, Cultured
5
2019
3896
0.110
Why?
Vidarabine
2
2018
26
0.110
Why?
Phenotype
2
2019
2815
0.110
Why?
Tumor Suppressor Proteins
1
2016
282
0.110
Why?
Gene Expression Profiling
3
2019
1523
0.110
Why?
Harringtonines
1
2013
2
0.110
Why?
Registries
2
2023
1763
0.110
Why?
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
2013
1
0.110
Why?
Glucose
1
2018
900
0.110
Why?
Alemtuzumab
3
2007
12
0.110
Why?
Gene Expression Regulation, Neoplastic
1
2018
1144
0.110
Why?
Pyridazines
1
2013
45
0.110
Why?
Carbon Monoxide
1
2013
65
0.110
Why?
Liver
1
2020
1681
0.100
Why?
Interleukin-1
1
2017
970
0.100
Why?
Nausea
1
2012
102
0.100
Why?
5-Methylcytosine
1
2012
16
0.100
Why?
Membrane Proteins
1
2018
1019
0.100
Why?
Vomiting
1
2012
124
0.100
Why?
Imidazoles
1
2013
209
0.100
Why?
Biopsy
1
2015
1046
0.100
Why?
Length of Stay
1
2016
950
0.100
Why?
Incidence
2
2016
2318
0.100
Why?
Software
1
2015
537
0.100
Why?
Core Binding Factor Alpha 2 Subunit
2
2023
31
0.090
Why?
Fatigue
1
2012
295
0.090
Why?
Cell Line, Tumor
5
2018
2715
0.090
Why?
Amino Acid Sequence
2
2015
1990
0.090
Why?
Dioxygenases
1
2010
25
0.090
Why?
Sesquiterpenes
2
2016
51
0.090
Why?
Ethanol
1
2015
548
0.090
Why?
Insulin Resistance
1
2018
1077
0.090
Why?
Chronic Disease
1
2016
1591
0.090
Why?
Oxidants
1
2011
112
0.090
Why?
GTP-Binding Proteins
1
2011
141
0.090
Why?
Wasp Venoms
1
2009
4
0.090
Why?
Protein Multimerization
1
2011
160
0.090
Why?
Injections, Subcutaneous
1
2009
133
0.080
Why?
Hydrogen Peroxide
1
2011
287
0.080
Why?
Mice, Transgenic
3
2023
1955
0.080
Why?
Emergencies
1
2009
147
0.080
Why?
Adjuvants, Immunologic
1
2010
206
0.080
Why?
Immunization Schedule
1
2010
184
0.080
Why?
Epinephrine
1
2009
167
0.080
Why?
RNA, Small Interfering
3
2016
541
0.080
Why?
Inflammation
1
2019
2485
0.080
Why?
Mice, Inbred C57BL
4
2020
4718
0.080
Why?
Melphalan
1
2007
29
0.070
Why?
Blood Transfusion
2
2020
276
0.070
Why?
Transplantation Chimera
1
2007
51
0.070
Why?
Tumor Cells, Cultured
2
2022
851
0.070
Why?
HEK293 Cells
2
2019
590
0.070
Why?
Karnofsky Performance Status
1
2006
36
0.070
Why?
Receptors, Thrombopoietin
2
2016
5
0.070
Why?
Protein-Tyrosine Kinases
3
2014
396
0.070
Why?
Exome
2
2018
201
0.070
Why?
Calreticulin
2
2016
24
0.070
Why?
Janus Kinase 2
2
2016
31
0.070
Why?
Ganciclovir
1
2006
49
0.070
Why?
Risk Factors
3
2014
8643
0.070
Why?
Evidence-Based Medicine
1
2010
676
0.070
Why?
Risk Assessment
3
2021
2976
0.070
Why?
Valine
1
2006
72
0.060
Why?
Acyclovir
1
2006
100
0.060
Why?
Cell Proliferation
3
2020
2191
0.060
Why?
Philadelphia Chromosome
2
2016
15
0.060
Why?
Bone Marrow Transplantation
1
2006
241
0.060
Why?
Oxidation-Reduction
2
2019
926
0.060
Why?
Pedigree
2
2015
467
0.060
Why?
Janus Kinases
2
2015
12
0.060
Why?
Breast Neoplasms
1
2015
1865
0.060
Why?
Cytomegalovirus Infections
1
2006
182
0.060
Why?
Diamines
1
2023
3
0.060
Why?
Xenograft Model Antitumor Assays
2
2016
697
0.060
Why?
Antigens, CD34
1
2023
89
0.050
Why?
Flow Cytometry
2
2018
1084
0.050
Why?
Chemotaxis
1
2023
130
0.050
Why?
Practice Guidelines as Topic
1
2010
1398
0.050
Why?
Angiogenesis Inhibitors
1
2004
214
0.050
Why?
Neutropenia
1
2022
125
0.050
Why?
Drug Interactions
2
2013
347
0.050
Why?
Early Termination of Clinical Trials
1
2021
14
0.050
Why?
Quinuclidines
1
2020
4
0.050
Why?
Clinical Trials, Phase II as Topic
1
2020
59
0.040
Why?
Receptors, Cell Surface
1
2022
354
0.040
Why?
Antiviral Agents
1
2006
647
0.040
Why?
Hyperbilirubinemia
1
2020
14
0.040
Why?
Niacinamide
1
2020
62
0.040
Why?
Proportional Hazards Models
2
2017
1080
0.040
Why?
Neoplasms, Second Primary
1
2021
92
0.040
Why?
Multicenter Studies as Topic
1
2020
250
0.040
Why?
Lentivirus
1
2019
45
0.040
Why?
Mice, Knockout
2
2016
2585
0.040
Why?
Iron
1
2020
234
0.040
Why?
Mice, Nude
2
2015
631
0.040
Why?
Disease Susceptibility
1
2021
316
0.040
Why?
Daunorubicin
1
2018
24
0.040
Why?
Consolidation Chemotherapy
1
2018
9
0.040
Why?
Drug Monitoring
1
2020
184
0.040
Why?
Maintenance Chemotherapy
1
2018
22
0.040
Why?
Disease Models, Animal
2
2020
3545
0.040
Why?
Mice, SCID
1
2019
319
0.040
Why?
Fetal Blood
1
2020
270
0.040
Why?
Myeloablative Agonists
1
2018
21
0.040
Why?
Cause of Death
1
2020
364
0.040
Why?
Clinical Decision-Making
1
2021
267
0.040
Why?
Datasets as Topic
1
2018
98
0.040
Why?
Forkhead Transcription Factors
1
2019
171
0.040
Why?
Antineoplastic Agents, Immunological
1
2020
152
0.040
Why?
Whole-Body Irradiation
1
2018
72
0.040
Why?
HLA Antigens
1
2019
224
0.040
Why?
Tumor Microenvironment
1
2020
431
0.040
Why?
Glutathione
1
2019
302
0.040
Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
12
0.040
Why?
Biological Transport
1
2018
372
0.040
Why?
Cell Count
1
2018
304
0.040
Why?
Glycolysis
1
2018
227
0.040
Why?
Combined Modality Therapy
1
2020
1127
0.040
Why?
Tumor Stem Cell Assay
1
2017
33
0.040
Why?
Diet, High-Fat
1
2018
225
0.040
Why?
Retinal Dehydrogenase
1
2017
39
0.040
Why?
Health Services Accessibility
1
2023
765
0.040
Why?
Transcriptome
1
2022
725
0.040
Why?
Adenosine Triphosphate
1
2019
431
0.030
Why?
Arsenicals
1
2017
24
0.030
Why?
Oxides
1
2017
43
0.030
Why?
Hydrazines
1
2016
28
0.030
Why?
Benzothiazoles
1
2016
33
0.030
Why?
Reactive Oxygen Species
1
2019
536
0.030
Why?
NADP
1
2016
42
0.030
Why?
Heterografts
1
2017
117
0.030
Why?
Cyclophosphamide
1
2017
217
0.030
Why?
Deoxyglucose
1
2016
43
0.030
Why?
Drug Combinations
1
2017
287
0.030
Why?
Sequence Analysis, RNA
1
2018
387
0.030
Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2016
12
0.030
Why?
Kinetics
1
2019
1558
0.030
Why?
Sample Size
1
2016
112
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2017
262
0.030
Why?
Receptors, Interleukin-1
1
2017
227
0.030
Why?
Positron-Emission Tomography
1
2017
275
0.030
Why?
Quality of Life
2
2016
2359
0.030
Why?
Isoenzymes
1
2016
286
0.030
Why?
Metabolome
1
2018
285
0.030
Why?
Lipid Metabolism
1
2018
449
0.030
Why?
Repressor Proteins
1
2018
368
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2017
331
0.030
Why?
Comorbidity
2
2013
1457
0.030
Why?
Splenomegaly
1
2015
18
0.030
Why?
Sirolimus
1
2016
181
0.030
Why?
Cell Differentiation
1
2022
1700
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2017
349
0.030
Why?
Hydroxyurea
1
2015
30
0.030
Why?
Diagnosis, Differential
1
2019
1355
0.030
Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
Why?
Ketone Oxidoreductases
1
2014
7
0.030
Why?
Fluorescent Antibody Technique
1
2015
396
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
55
0.030
Why?
Imatinib Mesylate
1
2014
63
0.030
Why?
Interleukin-1beta
1
2017
370
0.030
Why?
Immunologic Factors
1
2017
221
0.030
Why?
Sequence Homology, Amino Acid
1
2015
353
0.030
Why?
Age of Onset
1
2015
449
0.030
Why?
Dasatinib
1
2014
46
0.030
Why?
Research Design
1
2020
930
0.030
Why?
Superoxides
1
2014
214
0.030
Why?
Structure-Activity Relationship
1
2015
503
0.030
Why?
Genetic Heterogeneity
1
2014
49
0.030
Why?
Thiazoles
1
2014
110
0.030
Why?
Cyclosporine
1
2014
161
0.030
Why?
Drug Synergism
1
2014
317
0.030
Why?
Leukemia, Lymphoid
1
2013
27
0.030
Why?
Trans-Activators
1
2016
368
0.030
Why?
Up-Regulation
1
2016
812
0.030
Why?
Pulmonary Diffusing Capacity
1
2013
60
0.030
Why?
RNA Interference
1
2014
437
0.030
Why?
Phosphorylation
1
2017
1572
0.030
Why?
Polymorphism, Single Nucleotide
1
2020
1901
0.030
Why?
Mice, Inbred BALB C
1
2015
1153
0.030
Why?
Homeodomain Proteins
1
2016
464
0.030
Why?
Cost-Benefit Analysis
1
2015
544
0.030
Why?
Thrombosis
1
2015
301
0.020
Why?
Respiratory Function Tests
1
2013
523
0.020
Why?
Leupeptins
1
2011
10
0.020
Why?
HL-60 Cells
1
2011
28
0.020
Why?
Child
1
2010
18407
0.020
Why?
Blast Crisis
1
2011
19
0.020
Why?
Prospective Studies
2
2016
6232
0.020
Why?
Cysteine Proteinase Inhibitors
1
2011
45
0.020
Why?
Proteasome Inhibitors
1
2011
40
0.020
Why?
Mitoxantrone
1
2010
12
0.020
Why?
Free Radical Scavengers
1
2011
78
0.020
Why?
Genotype
1
2015
1780
0.020
Why?
Prevalence
1
2016
2255
0.020
Why?
Etoposide
1
2010
148
0.020
Why?
Proteasome Endopeptidase Complex
1
2011
134
0.020
Why?
Molecular Sequence Data
1
2015
2796
0.020
Why?
Neoplasms, Experimental
1
2011
151
0.020
Why?
Acetylcysteine
1
2011
142
0.020
Why?
Mutagenesis, Site-Directed
1
2011
345
0.020
Why?
Models, Biological
1
2017
1636
0.020
Why?
Treatment Failure
1
2010
332
0.020
Why?
Insulin
1
2018
2082
0.020
Why?
RNA-Binding Proteins
1
2011
352
0.020
Why?
Nitroimidazoles
1
2004
6
0.010
Why?
Cyclohexanes
1
2004
22
0.010
Why?
Fluorescein
1
2004
26
0.010
Why?
In Situ Nick-End Labeling
1
2004
119
0.010
Why?
Lectins
1
2004
44
0.010
Why?
Radiation-Sensitizing Agents
1
2004
38
0.010
Why?
Capillaries
1
2004
91
0.010
Why?
Neoplasm Transplantation
1
2004
230
0.010
Why?
Microcirculation
1
2004
135
0.010
Why?
In Situ Hybridization
1
2004
292
0.010
Why?
Antibiotics, Antineoplastic
1
2004
109
0.010
Why?
Angiography
1
2004
177
0.010
Why?
Wilms Tumor
1
2004
68
0.010
Why?
Neovascularization, Pathologic
1
2004
281
0.010
Why?
Vascular Endothelial Growth Factor A
1
2004
499
0.010
Why?
Immunohistochemistry
1
2004
1634
0.010
Why?
Hypoxia
1
2004
958
0.010
Why?
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)